Lipid transport and signaling in Caenorhabditis elegans

Developmental Dynamics

Volumn 239, Issue 5, 2010, Pages 1365-1377

  Branicky, Robyn ^a,b   Desjardins, David ^a   Liu, Ju Ling ^a   Hekimi, Siegfried ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

Caenorhabditis elegans; Cholesterol; Dafachronic acid; Dauer formation; Daumone; Defecation; Germline; LDL; Lipid; Lipid signaling; Lipoprotein; Polyunsaturated fatty acids; PUFA; Reverse cholesterol transport; Sperm motility; Vitellogenin

Indexed keywords

FATTY ACID DERIVATIVE; LINOLEIC ACID; LIPOPROTEIN; PHEROMONE; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UBIQUINONE;

ATHEROSCLEROSIS; CAENORHABDITIS ELEGANS; DYSLIPIDEMIA; LIPID OXIDATION; LIPID TRANSPORT; NONHUMAN; PRENYLATION; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGICAL TRANSPORT; CAENORHABDITIS ELEGANS; HUMANS; LIPASE; LIPID METABOLISM; LIPOPROTEINS; SIGNAL TRANSDUCTION;

ANIMALIA; CAENORHABDITIS ELEGANS;

EID: 77951593598     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.22234     Document Type: Review

References (100)

1. Albert MA, Danielson E, Rifai N, Ridker PM. 2001. Effect of statin therapy on Creactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA 286:64-70. (Pubitemid 32606333)
2. Antebi A, Yeh WH, Tait D, Hedgecock EM, Riddle DL. 2000. daf-12 encodes a nuclear receptor that regulates the dauer diapause and developmental age in C. elegans. Genes Dev 14:1512-1527. (Pubitemid 30421843)
3. Ashrafi K. 2007. Obesity and the regulation of fat metabolism. WormBook:1-20.
4. Bethke A, Fielenbach N, Wang Z, Mangelsdorf DJ, Antebi A. 2009. Nuclear hormone receptor regulation of micro-RNAs controls developmental progression. Science 324:95-98.
5. Blasiole DA, Davis RA, Attie AD. 2007. The physiological and molecular regulation of lipoprotein assembly and secretion. Mol Biosyst 3:608-619. (Pubitemid 47258227)
6. Blumenthal T, Squire M, Kirtland S, Cane J, Donegan M, Spieth J, Sharrock W. 1984. Cloning of a yolk protein gene family from Caenorhabditis elegans. J Mol Biol 174:1-18.
7. Branicky R, Hekimi S. 2006. What keeps C. elegans regular: the genetics of defecation. Trends Genet 22:571-579. (Pubitemid 44374130)
8. Branicky R, Shibata Y, Feng J, Hekimi S. 2001. Phenotypic and suppressor analysis of defecation in clk-1 mutants reveals that reaction to changes in temperature is an active process in Caenorhabditis elegans. Genetics 159:997-1006. (Pubitemid 34033446)
9. Brodsky JL, Fisher EA. 2008. The many intersecting pathways underlying apolipoprotein B secretion and degradation. Trends Endocrinol Metab 19:254-259.
10. Brown AL, Liao Z, Goodman MB. 2008. MEC-2 and MEC-6 in the Caenorhabditis elegans sensory mechanotransduction complex: auxiliary subunits that enable channel activity. J Gen Physiol 131:605-616. (Pubitemid 351749200)
11. Burnett JR, Watts GF. 2007. MTP inhibition as a treatment for dyslipidaemias: time to deliver or empty promises? Expert Opin Ther Targets 11:181-189.
12. Butcher RA, FujitaM, Schroeder FC, Clardy J. 2007. Small-molecule pheromones that control dauer development in Caenorhabditis elegans. Nat ChemBiol 3:420-422. (Pubitemid 46956322)
13. Butcher RA, Ragains JR, Li W, Ruvkun G, Clardy J, Mak HY. 2009. Biosynthesis of the Caenorhabditis elegans dauer pheromone. Proc Natl Acad Sci U S A 106:1875-1879.
14. Chang TY, Chang CC, Ohgami N, Yamauchi Y. 2006. Cholesterol sensing, trafficking, and esterification. Annu Rev Cell Dev Biol 22:129-157.
15. Chen S, Whetstine JR, Ghosh S, Hanover JA, Gali RR, Grosu P, Shi Y. 2009. The conserved NAD(H)-dependent corepressor CTBP-1 regulates Caenorhabditis elegans life span. Proc Natl Acad Sci U S A 106:1496-1501.
16. Choy RK, Thomas JH. 1999. Fluoxetine-resistant mutants in C. elegans define a novel family of transmembrane proteins. Mol Cell 4:143-152. (Pubitemid 29456883)
17. Choy RK, Kemner JM, Thomas JH. 2006. Fluoxetine-resistance genes in Caenorhabditis elegans function in the intestine and may act in drug transport. Genetics 172:885-892.
18. de Bono M, Bargmann CI. 1998. Natural variation in a neuropeptide Y receptor homolog modifies social behavior and food response in C. elegans. Cell 94:679-689.
19. Duffy D, Rader DJ. 2009. Update on strategies to increase HDL quantity and function. Nat Rev Cardiol 6:455-463.
20. Edison AS. 2009. Caenorhabditis elegans pheromones regulate multiple complex behaviors. Curr Opin Neurobiol 19:378-388.
21. Entchev EV, Kurzchalia TV. 2005. Requirement of sterols in the life cycle of the nematode Caenorhabditis elegans. Semin Cell Dev Biol 16:175-182.
22. Entchev EV, Schwudke D, Zagoriy V, Matyash V, Bogdanova A, Habermann B, Zhu L, Shevchenko A, Kurzchalia TV. 2008. LET-767 is required for the production of branched chain and long chain fatty acids in Caenorhabditis elegans. J Biol Chem 283:17550-17560.
23. Gerisch B, Weitzel C, Kober-Eisermann C, Rottiers V, Antebi A. 2001. A hormonal signaling pathway influencing C. elegans metabolism, reproductive development, and life span. Dev Cell 1:841-851. (Pubitemid 33586137)
24. Gerisch B, Rottiers V, Li D, Motola DL, Cummins CL, Lehrach H, Mangelsdorf DJ, Antebi A. 2007. A bile acid-like steroid modulates Caenorhabditis elegans lifespan through nuclear receptor signaling. Proc Natl Acad Sci U S A 104:5014-5019. (Pubitemid 47186168)
25. Gill MS, Held JM, Fisher AL, Gibson BW, Lithgow GJ. 2004. Lipophilic regulator of a developmental switch in Caenorhabditis elegans. Aging Cell 3:413-421.
26. Gissendanner CR, Sluder AE. 2000. nhr-25, the Caenorhabditis elegans ortholog of ftz-f1, is required for epidermal and somatic gonad development. Dev Biol 221:259-272.
27. Goodman MB. 2006. Mechanosensation. WormBook:1-14.
28. Grant B, Hirsh D. 1999. Receptor-mediated endocytosis in the Caenorhabditis elegans oocyte. Mol Biol Cell 10:4311-4326.
29. Grigorenko AP, Moliaka YK, Soto MC, Mello CC, Rogaev EI. 2004. The Caenorhabditis elegans IMPAS gene, imp-2, is essential for development and is functionally distinct from related presenilins. Proc Natl Acad Sci U S A 101:14955-14960.
30. Hannun YA, Obeid LM. 2008. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9:139-150.
31. Hara M, Han M. 1995. Ras farnesyltransferase inhibitors suppress the phenotype resulting from an activated ras mutation in Caenorhabditis elegans. Proc Natl Acad Sci U S A 92:3333-3337.
32. Held JM, White MP, Fisher AL, Gibson BW, Lithgow GJ, Gill MS. 2006. DAF-12-dependent rescue of dauer formation in Caenorhabditis elegans by (25S)-cholestenoic acid. Aging Cell 5:283-291. (Pubitemid 44103243)
33. Hihi AK, Beauchamp MC, Branicky R, Desjardins A, Casanova I, Guimond MP, Carroll M, Ethier M, Kianicka I, McBride K, Hekimi S. 2008. Evolutionary conservation of drug action on lipoprotein metabolism-related targets. J Lipid Res 49:74-83.
34. Hu PJ. 2007. Dauer. WormBook:1-19.
35. Huber TB, Schermer B, Muller RU, Hohne M, Bartram M, Calixto A, Hagmann H, Reinhardt C, Koos F, Kunzelmann K, Shirokova E, Krautwurst D, Harteneck C, Simons M, Pavenstadt H, Kerjaschki D, Thiele C, Walz G, Chalfie M, Benzing T. 2006. Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels. Proc Natl Acad Sci U S A 103:17079-17086.
36. Jeong PY, Jung M, Yim YH, Kim H, Park M, Hong E, Lee W, Kim YH, Kim K, Paik YK. 2005. Chemical structure and biological activity of the Caenorhabditis elegans dauer-inducing pheromone. Nature 433:541-545.
37. Jia K, Albert PS, Riddle DL. 2002. DAF-9, a cytochrome P450 regulating C. elegans larval development and adult longevity. Development 129:221-231.
38. Jo H, Shim J, Lee JH, Lee J, Kim JB. 2009. IRE-1 and HSP-4 contribute to energy homeostasis via fasting-induced lipases in C. elegans. Cell Metab 9:440-448.
39. Jones KT, Ashra. K. 2009. Caenorhabditis elegans as an emerging model for studying the basic biology of obesity. Dis Model Mech 2:224-229.
40. Joo HJ, Yim YH, Jeong PY, Jin YX, Lee JE, Kim H, Jeong SK, Chitwood DJ, Paik YK. 2009. Caenorhabditis elegans utilizes dauer pheromone biosynthesis to dispose of toxic peroxisomal fatty acids for cellular homoeostasis. Biochem J 422:61-71.
41. Kahn-Kirby AH, Dantzker JL, Apicella AJ, Schafer WR, Browse J, Bargmann CI, Watts JL. 2004. Specific polyunsaturated fatty acids drive TRPV-dependent sensory signaling in vivo. Cell 119:889-900.
42. Kamikura DM, Cooper JA. 2003. Lipoprotein receptors and a disabled family cytoplasmic adaptor protein regulate EGL-17/FGF export in C. elegans. Genes Dev 17:2798-2811.
43. Kayser EB, Sedensky MM, Morgan PG. 2004. The effects of complex I function and oxidative damage on lifespan and anesthetic sensitivity in Caenorhabditis elegans. Mech Ageing Dev 125:455-464.
44. Kimble J, Sharrock WJ. 1983. Tissue-specific synthesis of yolk proteins in Caenorhabditis elegans. Dev Biol 96:189-196.
45. Kniazeva M, Sieber M, McCauley S, Zhang K, Watts JL, Han M. 2003. Suppression of the ELO-2 FA elongation activity results in alterations of the fatty acid composition and multiple physiological defects, including abnormal ultradian rhythms, in Caenorhabditis elegans. Genetics 163:159-169.
46. Kniazeva M, Crawford QT, Seiber M, Wang CY, Han M. 2004. Monomethyl branched-chain fatty acids play an essential role in Caenorhabditis elegans development. PLoS Biol 2:E257.
47. Kniazeva M, Euler T, Han M. 2008. A branched-chain fatty acid is involved in post-embryonic growth control in parallel to the insulin receptor pathway and its biosynthesis is feedback-regulated in C. elegans. Genes Dev 22:2102-2110.
48. Kostrouchova M, Krause M, Kostrouch Z, Rall JE. 1998. CHR3: a Caenorhabditis elegans orphan nuclear hormone receptor required for proper epidermal development and molting. Development 125:1617-1626.
49. Kostrouchova M, Krause M, Kostrouch Z, Rall JE. 2001. Nuclear hormone receptor CHR3 is a critical regulator of all four larval molts of the nematode Caenorhabditis elegans. Proc Natl Acad Sci U S A 98:7360-7365.
50. Kubagawa HM, Watts JL, Corrigan C, Edmonds JW, Sztul E, Browse J, Miller MA. 2006. Oocyte signals derived from polyunsaturated fatty acids control sperm recruitment in vivo. Nat Cell Biol 8:1143-1148.
51. Kuervers LM, Jones CL, O'Neil NJ, Baillie DL. 2003. The sterol modifying enzyme LET-767 is essential for growth, reproduction and development in Caenorhabditis elegans. Mol Genet Genomics 270:121-131.
52. Kurzchalia TV, Ward S. 2003. Why do worms need cholesterol? Nat Cell Biol 5:684-688.
53. Lajoie P, Goetz JG, Dennis JW, Nabi IR. 2009. Lattices, rafts, and scaffolds: domain regulation of receptor signaling at the plasma membrane. J Cell Biol 185:381-385.
54. Lapointe J, Hekimi S. 2008. Early mitochondrial dysfunction in long-lived Mclk1+/- mice. J Biol Chem 283:26217-26227.
55. Li J, Brown G, Ailion M, Lee S, Thomas JH. 2004. NCR-1 and NCR-2, the C. elegans homologs of the human Niemann-Pick type C1 disease protein, function upstream of DAF-9 in the dauer formation pathways. Development 131:5741-5752.
56. Ludewig AH, Kober-Eisermann C,Weitzel C, Bethke A, Neubert K, Gerisch B, Hutter H, Antebi A. 2004. A novel nuclear receptor/coregulator complex controls C. elegans lipid metabolism, larval development, and aging. Genes Dev 18:2120-2133.
57. Lusis AJ. 2000. Atherosclerosis. Nature 407:233-241.
58. Luster AD, Tager AM. 2004. T-cell trafficking in asthma: lipid mediators grease the way. Nat Rev Immunol 4: 711-724.
59. Ma PT, Gil G, Sudhof TC, Bilheimer DW, Goldstein JL, Brown MS. 1986. Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits. Proc Natl Acad Sci U S A 83:8370-8374.
60. Macosko EZ, Pokala N, Feinberg EH, Chalasani SH, Butcher RA, Clardy J, Bargmann CI. 2009. A hub-and-spoke circuit drives pheromone attraction and social behaviour in C. elegans. Nature 458:1171-1175.
61. Marza E, Lesa GM. 2006. Polyunsaturated fatty acids and neurotransmission in Caenorhabditis elegans. Biochem Soc Trans 34:77-80.
62. Marza E, Long T, Saiardi A, Sumakovic M, Eimer S, Hall DH, Lesa GM. 2008. Polyunsaturated fatty acids influence synaptojanin localization to regulate synaptic vesicle recycling. Mol Biol Cell 19:833-842.
63. Matyash V, Geier C, Henske A, Mukherjee S, Hirsh D, Thiele C, Grant B, Maxfield FR, Kurzchalia TV. 2001. Distribution and transport of cholesterol in Caenorhabditis elegans. Mol Biol Cell 12:1725-1736.
64. Matyash V, Entchev EV, Mende F, Wilsch-Brauninger M, Thiele C, Schmidt AW, Knolker HJ, Ward S, Kurzchalia TV. 2004. Sterol-derived hormone(s) controls entry into diapause in Caenorhabditis elegans by consecutive activation of DAF-12 and DAF-16. PLoS Biol 2:e280.
65. McMahon HT, Gallop JL. 2005. Membrane curvature and mechanisms of dynamic cell membrane remodelling. Nature 438:590-596.
66. Morck C, Olsen L, Kurth C, Persson A, Storm NJ, Svensson E, Jansson JO, Hellqvist M, Enejder A, Faergeman NJ, Pilon M. 2009. Statins inhibit protein lipidation and induce the unfolded protein response in the non-sterol producing nematode Caenorhabditis elegans. Proc Natl Acad Sci U S A 106:18285-18290.
67. Motola DL, Cummins CL, Rottiers V, Sharma KK, Li T, Li Y, Suino-Powell K, Xu HE, Auchus RJ, Antebi A, Mangelsdorf DJ. 2006. Identification of ligands for DAF-12 that govern dauer formation and reproduction in C. elegans. Cell 124:1209-1223.
68. Narbonne P, Roy R. 2009. Caenorhabditis elegans dauers need LKB1/AMPK to ration lipid reserves and ensure long-term survival. Nature 457:210-214.
69. Nieland TJ, Shaw JT, Jaipuri FA, Maliga Z, Duffner JL, Koehler AN, Krieger M. 2007. Influence of HDL-cholesterol-elevating drugs on the in vitro activity of the HDL receptor SR-BI. J Lipid Res 48:1832-1845.
70. Ohkura K, Suzuki N, Ishihara T, Katsura I. 2003. SDF-9, a protein tyrosine phosphatase-like molecule, regulates the L3/dauer developmental decision through hormonal signaling in C. elegans. Development 130:3237-3248.
71. Pan M, Cederbaum AI, Zhang YL, Ginsberg HN, Williams KJ, Fisher EA. 2004. Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production. J Clin Invest 113:1277-1287.
72. Parker S, Walker DS, Ly S, Baylis HA. 2009. Caveolin-2 is required for apical lipid trafficking and suppresses basolateral recycling defects in the intestine of Caenorhabditis elegans. Mol Biol Cell 20:1763-1771.
73. Parton RG, Simons K. 2007. The multiple faces of caveolae. Nat Rev Mol Cell Biol 8:185-194.
74. Patel DS, Fang LL, Svy DK, Ruvkun G, Li W. 2008. Genetic identification of HSD-1, a conserved steroidogenic enzyme that directs larval development in Caenorhabditis elegans. Development 135:2239-2249.
75. Ray KK, Cannon CP. 2004. Pathological changes in acute coronary syndromes: the role of statin therapy in the modulation of inflammation, endothelial function and coagulation. J Thromb Thrombolysis 18:89-101.
76. Rottiers V, Motola DL, Gerisch B, Cummins CL, Nishiwaki K, Mangelsdorf DJ, Antebi A. 2006. Hormonal control of C. elegans dauer formation and life span by a Rieske-like oxygenase. Dev Cell 10:473-482.
77. Schedin P, Hunter CP, Wood WB. 1991. Autonomy and nonautonomy of sex determination in triploid intersex mosaics of C. elegans. Development 112:863-879.
78. Scheel J, Srinivasan J, Honnert U, Henske A, Kurzchalia TV. 1999. Involvement of caveolin-1 in meiotic cell-cycle progression in Caenorhabditis elegans. Nat Cell Biol 1:127-129.
79. Schertzer JW, Boulette ML, Whiteley M. 2009. More than a signal: non-signaling properties of quorum sensing molecules. Trends Microbiol 17:189-195.
80. Seamen E, Blanchette JM, Han M. 2009. P-type ATPase TAT-2 negatively regulates monomethyl branched-chain fatty acid mediated function in post-embryonic growth and development in C. elegans. PLoS Genet 5:e1000589.
81. Sellers JA, Hou L, Schoenberg DR, Batistuzzo de Medeiros SR, Wahli W, Shelness GS. 2005. Microsomal triglyceride transfer protein promotes the secretion of Xenopus laevis vitellogenin A1. J Biol Chem 280:13902-13905.
82. Shibata Y, Branicky R, Landaverde IO, Hekimi S. 2003. Redox regulation of germline and vulval development in Caenorhabditis elegans. Science 302:1779-1782.
83. Shimizu T. 2009. Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Annu Rev Pharmacol Toxicol 49:123-150.
84. Shostak Y, Van Gilst MR, Antebi A, Yamamoto KR. 2004. Identification of C. elegans DAF-12-binding sites, response elements, and target genes. Genes Dev 18:2529-2544.
85. Shoulders CC, Shelness GS. 2005. Current biology of MTP: implications for selective inhibition. Curr Top Med Chem 5:283-300.
86. Simon JM, Sternberg PW. 2002. Evidence of a mate-finding cue in the hermaphrodite nematode Caenorhabditis elegans. Proc Natl Acad Sci U S A 99:1598-1603.
87. Smith MM, Levitan DJ. 2007. Human NPC1L1 and NPC1 can functionally substitute for the ncr genes to promote reproductive development in C. elegans. Biochim Biophys Acta 1770:1345-1351.
88. Smolenaars MM, Madsen O, Rodenburg KW, Van der Horst DJ. 2007. Molecular diversity and evolution of the large lipid transfer protein superfamily. J Lipid Res 48:489-502.
89. Spieth J, Blumenthal T. 1985. The Caenorhabditis elegans vitellogenin gene family includes a gene encoding a distantly related protein. Mol Cell Biol 5:2495-2501.
90. Srinivasan J, Kaplan F, Ajredini R, Zachariah C, Alborn HT, Teal PE, Malik RU, Edison AS, Sternberg PW, Schroeder FC. 2008. A blend of small molecules regulates both mating and development in Caenorhabditis elegans. Nature 454:1115-1118.
91. Stepanyan Z, Hughes B, Cliche DO, Camp D, Hekimi S. 2006. Genetic and molecular characterization of CLK-1/mCLK1, a conserved determinant of the rate of aging. Exp Gerontol 41:940-951.
92. Sud M, Fahy E, Cotter D, Brown A, Dennis EA, Glass CK, Merrill AH Jr, Murphy RC, Raetz CR, Russell DW, Subramaniam S. 2007. LMSD: LIPID MAPS structure database. Nucleic Acids Res 35:D527-D532.
93. Sym M, Basson M, Johnson C. 2000. A model for niemann-pick type C disease in the nematode Caenorhabditis elegans. Curr Biol 10:527-530.
94. Uchiyama S, Shimizu T, Shirasawa T. 2006. CuZn-SOD deficiency causes ApoB degradation and induces hepatic lipid accumulation by impaired lipoprotein secretion in mice. J Biol Chem 281:31713-31719.
95. Wang MC, O'Rourke EJ, Ruvkun G. 2008. Fat metabolism links germline stem cells and longevity in C. elegans. Science 322:957-960.
96. Watts JL. 2009. Fat synthesis and adiposity regulation in Caenorhabditis elegans. Trends Endocrinol Metab 20:58-65.
97. Watts JL, Browse J. 2006. Dietary manipulation implicates lipid signaling in the regulation of germ cell maintenance in C. elegans. Dev Biol 292:381-392.
98. Watts JL, Phillips E, Griffing KR, Browse J. 2003. Deficiencies in C20 polyunsaturated fatty acids cause behavioral and developmental defects in Caenorhabditis elegans fat-3 mutants. Genetics 163:581-589.
99. Yang W, Li J, Hekimi S. 2007. A Measurable increase in oxidative damage due to reduction in superoxide detoxification fails to shorten the life span of longlived mitochondrial mutants of Caenorhabditis elegans. Genetics 177:2063-2074.
100. Yochem J, Tuck S, Greenwald I, Han M. 1999. A gp330/megalin-related protein is required in the major epidermis of Caenorhabditis elegans for completion of molting. Development 126:597-606.